CN1121426A - Traditional Chinese medicine for curing anemia - Google Patents

Traditional Chinese medicine for curing anemia Download PDF

Info

Publication number
CN1121426A
CN1121426A CN95102249A CN95102249A CN1121426A CN 1121426 A CN1121426 A CN 1121426A CN 95102249 A CN95102249 A CN 95102249A CN 95102249 A CN95102249 A CN 95102249A CN 1121426 A CN1121426 A CN 1121426A
Authority
CN
China
Prior art keywords
anemia
chinese medicine
medicine
blood
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN95102249A
Other languages
Chinese (zh)
Other versions
CN1049143C (en
Inventor
王泰麟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN95102249A priority Critical patent/CN1049143C/en
Publication of CN1121426A publication Critical patent/CN1121426A/en
Application granted granted Critical
Publication of CN1049143C publication Critical patent/CN1049143C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invented drug uses rhizome of Chinese atractylodes as main drug and is made up by mixing it with medicated leaven, green vitriol, tortoise-shell and pilose antler. It has efficacy of promoting the production of blood and enriching the blood and the following advantages: effective for the anaemia caused by multiple kinds of pathogeny, total effective rate over 95%, rapidly becoming effective, convenient for taking, low cost, side effect free and effecting a permanent cure.

Description

A kind of Chinese medicine for the treatment of anemia
The present invention relates to a kind of Chinese medicinal capsule (hemopoietic health) for the treatment of the anemia that multiple factor causes.
Anemia is a kind of commonly encountered diseases, frequently-occurring disease, and the anemia kind is a lot, cause of disease complexity.According to the theory of Chinese medicine, the source of blood with generate the function mainly depend on taste and kidney, " Ling Shu Miraculous Pivot or Divine Axis, the gas of determining " piece of writing carries " middle Jiao is bullied that extracting juice changes and red, is to call blood ".Present medicine for the treatment of anemia clinically has multiple, and Western medicine has vitamin B 12, ferrous sulfate, folic acid etc., Chinese medicine have XUEBAO, FUFANG EJIAO JIANG etc., and the anemia cause of disease specific aim that these medicines are treated is single, as vitamin B 12Be primarily aimed at B 12Lack the anemia that causes, ferrous sulfate is primarily aimed at the anemia that iron deficiency causes, and onset is unhappy, and curative effect is low, and the state of an illness is difficult for radical cure easily repeatedly.
Purpose of the present invention will be developed a kind of wide at the cause of disease exactly, and the curative effect height is rapid-action, taking convenience, the medicine of low-cost treatment anemia.
According to clinical experience for many years, sum up effective prescription of having concluded the treatment anemia, through repeatedly adjusting and improving, prescription element has been implemented spleen invigorating system liver, iron supplement hemopoietic, the principle of enriching yin and nourishing kidney.With Rhizoma Atractylodis is monarch, and the acrid in the mouth hardship is warm in nature, has the dampness expectorant, transfers the effect of stomach feed; Get Massa Medicata Fermentata, Melanteritum is a minister, has drying dampness to eliminate phlegm, helps the effect of native spleen invigorating, and Melanteritum also can be lumbered and be made liver, the effect of iron supplement hemopoietic; A left side is with Carapax Et Plastrum Testudinis, and salty in the mouth is sweet, has nourishing YIN and supplementing blood, educates the Yin and Yang effect; Select Cornu Cervi Pantotrichum for making, salty in the mouth is warm in nature, has the replenishing essence marrow, mends the effect of kidney-Yang.The medicine made from above five kinds of Chinese medicine of the present invention has the effect that hemopoietic is enriched blood, and feeble QI distinguishes the flavor of, and is puckery, energy QI invigorating activating the spleen, and the replenishing essence stomach reinforcing promotes, recovers, regulates hemopoietic function.
Medicine preparation technology of the present invention is as follows: at first raw material is done pre-treatment, and the Rhizoma Atractylodis section, Massa Medicata Fermentata is fried, Carapax Et Plastrum Testudinis vinegar system, the Cornu Cervi Pantotrichum unhairing, it is red that the Melanteritum calcine becomes.Rhizoma Atractylodis are decocted with water three times then, each 2 hours, collect and press hair oil, seal up for safekeeping, the secondary decocting liquid is merged, filter, decocting and concentrating is to thick paste again.All the other four medicated powder are broken into fine powder, add in the thick paste, stir, and drying is ground into powder again, evenly spray Rhzoma Atractylodis Lanceae volatile oil in powder, put into capsule at last and are finished product.
The embodiment of medicine of the present invention is as follows: raw material is by following prescription batching, Rhizoma Atractylodis 20-40% (weight), Massa Medicata Fermentata 16-30% (weight), Melanteritum 20-35% (weight), Carapax Et Plastrum Testudinis 8-20% (weight), Cornu Cervi Pantotrichum 2-6% (weight).Be made as patent medicine by above-mentioned processing technology.The patient takes three every day, takes 2 grams for every, and child's consumption cuts down according to the circumstance, and obeying for two weeks is a course of treatment.
Since 1987, example surplus medicine of the present invention treatment patient 1200, total effective rate reaches more than 95%, iron deficiency anemia 460 examples wherein, malnutritional anemia 340 examples, hemorrhagic anemia 170 examples, leukopenia 330 examples.19941015, the medicine clinical case checking report of the present invention that the attached the People's Hospital of Beijing Medical University is gone out is pointed out: 33 patients take, and wherein take for 1 on time, all the other 32 to have changed hematochrome after three weeks took low, pale complexion, and appetite is poor, sleep disorder, symptoms such as body weight is light, hematochrome all rise to the normal index of World Health Organization's regulation, and complexion transfers to ruddy, appetite is promoted, weight increase has no adverse reaction, and total effective rate reaches 97%.
Model case is as follows:
1, Feng Xiaohua, woman, 40 years old, anemia 9 years, fatigue and weak, nervous breathing hard, have a dizzy spell, can not work, repeatedly treatment blood transfusion, chemical examination on May 21st, 92, hematochrome 6g, leukocyte 3150, obey two weeks of medicine of the present invention, chemical examination on June 3rd, 92, hematochrome 8g, leukocyte 5400 obeyed for two weeks again, chemical examination on June 15th, 92, hematochrome 10.5g, leukocyte 5600 obeyed for two weeks again, chemical examination on July 1st, 92, hematochrome 12g, leukocyte 5600, all transference cures, antisecosis continues three weeks of taking medicine again, follow up a case by regular visits to more than 2 years, not recurrence again.
2, kingly way is bright, and the man 25 years old, did not feel like a meal in two months, weak breath is weak, can not work emaciation and sallow complexion, thready pulse without strength, 94 on July 28, blood test pigments 8g, leukocyte 3100 is obeyed two weeks of medicine of the present invention, August 10 chemical examination, hematochrome 10.5g, leukocyte 4100 was taken medicine for two weeks again, chemical examination on August 24, hematochrome rises to 12.5g, leukocyte 6100, antisecosis, appetite heightens, and can participate in heavy physical labour.
3, Duan Xiaodong, the woman 40 years old, had 20 years so far from 20 years old anemia, through multi-treatment, hematochrome does not surpass 8g, for a long time can not be tired, menorrhagia, frequent flu, take medicine of the present invention in August, 93 after, spirit takes a turn for the better, and serve on for six weeks, and hematochrome increases to 12g, after took continuously for two weeks again, symptom all disappears, appetite increases, have no interest winter, the eumenorrhea, can do taskwork.
Medical instrument of the present invention has following advantages: the anemia that 1) many reasons is caused has treatment Effect, such as iron-deficient, dystrophic, antenatal rear anaemia, the weakness due to chronic disease chronic anaemia, Blood platelet is descended, and reduction of leukocyte also has preferably corrective action. 2) curative effect height, total Efficient reaching more than 95%. 3) rapid-action, to the patient of no complication, only take this Bright medicine is just seen curative effect after one week, the hemochrome 1-1.5g that rises weekly, and leucocyte also has bright Aobvious rising. 4) cost is low, and taking convenience need be in hospital to no complication patient, no Need blood transfusion, medical expense is low. 5) without any side effects. 6) no longer recurrence after the recovery from illness reaches To the purpose of once effecting a permanent cure.

Claims (2)

1, a kind of Chinese medicine (hemopoietic health) for the treatment of anemia has Melanteritum, it is characterized in that containing Rhizoma Atractylodis, Massa Medicata Fermentata, Carapax Et Plastrum Testudinis, Cornu Cervi Pantotrichum.
2, the Chinese medicine of treatment anemia according to claim 1 is characterized in that Rhizoma Atractylodis content is 20-40% (weight), and Massa Medicata Fermentata content is 16-30% (weight), and Carapax Et Plastrum Testudinis content is 8-20% (weight), and Cornu Cervi Pantotrichum content is 2-6% (weight)
CN95102249A 1995-03-15 1995-03-15 Traditional Chinese medicine for curing anemia Expired - Fee Related CN1049143C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN95102249A CN1049143C (en) 1995-03-15 1995-03-15 Traditional Chinese medicine for curing anemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN95102249A CN1049143C (en) 1995-03-15 1995-03-15 Traditional Chinese medicine for curing anemia

Publications (2)

Publication Number Publication Date
CN1121426A true CN1121426A (en) 1996-05-01
CN1049143C CN1049143C (en) 2000-02-09

Family

ID=5074251

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95102249A Expired - Fee Related CN1049143C (en) 1995-03-15 1995-03-15 Traditional Chinese medicine for curing anemia

Country Status (1)

Country Link
CN (1) CN1049143C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102688272A (en) * 2012-06-15 2012-09-26 贾茹 Preparation method for medicine for treating anaemia
CN102920834A (en) * 2012-11-23 2013-02-13 深圳市佳泰药业股份有限公司 Lvrong blood nourishing capsule and preparation method thereof
CN108837081A (en) * 2018-08-03 2018-11-20 广东佳泰药业股份有限公司 A kind of formula and production technology of Lvrong blood nourishing capsule

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102688272A (en) * 2012-06-15 2012-09-26 贾茹 Preparation method for medicine for treating anaemia
CN102688272B (en) * 2012-06-15 2013-09-11 贾茹 Preparation method for medicine for treating anaemia
CN102920834A (en) * 2012-11-23 2013-02-13 深圳市佳泰药业股份有限公司 Lvrong blood nourishing capsule and preparation method thereof
CN108837081A (en) * 2018-08-03 2018-11-20 广东佳泰药业股份有限公司 A kind of formula and production technology of Lvrong blood nourishing capsule

Also Published As

Publication number Publication date
CN1049143C (en) 2000-02-09

Similar Documents

Publication Publication Date Title
CN1056073C (en) Nutritious health-care oral liquor
CN1312102A (en) Life essence-filling, marrow-benefitting and kidney invigorating Chinese medicine preparation
CN102228595A (en) Chinese prescription energy pure Chinese medicine extract with anti-aging function
CN103372135A (en) Chinese medicinal composition treating cardiovascular and cerebrovascular diseases caused by heart-kidney imbalance
CN104940645A (en) Dendrobium officinale traditional Chinese medicine composition with functions of maintaining beauty and keeping young and preparation of dendrobium officinale traditional Chinese medicine composition
CN102716409B (en) Traditional Chinese medicine composition for tonifying qi and nourishing blood
CN111956701A (en) Chinese medicine for tonifying qi and blood, treating sub-health and preventing cancer and preparation method thereof
CN1049143C (en) Traditional Chinese medicine for curing anemia
CN1325099C (en) Mine-tranquilizing soporific capsule
CN1286508C (en) Compound health tea
CN103156956B (en) Blood replenishing oral liquid and preparation method thereof
CN109588720A (en) A kind of health food and preparation method thereof with raising anoxia endurance effect
CN101229358A (en) Chinese traditional medicine compounds for treating pneumonia, emphysema and preparing method thereof
CN103381249B (en) Immune enhancement Hepialus American ginseng preparation and capsule preparation technique thereof
CN1285378C (en) Nourishing wine for regulating human body balance function
CN1294983C (en) Medicine for treating facial paralysis and its preparing method
CN1293971A (en) Medicine for treating apoplexy and its preparing process
CN1125580A (en) Patent drug for anti-decrepitude
CN1730006A (en) Pharmaceutical composition for treating lung and kidney deficiency and qi, yin insufficiency and preparation method thereof
CN101264161A (en) Qi-benefitting nourishing blood-nourishing sedatives and preparation thereof
CN105497783A (en) Application of traditional Chinese medicine preparation to preparing drug for treating qi stagnation and blood stasis type chloasma
CN1947759A (en) Traditional Chinese medicine pills for taking care of user's beauty and making user younger
CN109620947A (en) U.S. face nti-freckle Chinese materia medica preparation
CN1060656C (en) Yuganwan pill-medicine for hepatitis
CN102698183B (en) Dangshen Chinese medicinal preparation for treating dizziness and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee